verapamil and tryptophyl-histidine

verapamil has been researched along with tryptophyl-histidine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kobayashi, Y; Matsui, T; Tanaka, M; Wang, Z; Watanabe, S	1

Other Studies

1 other study(ies) available for verapamil and tryptophyl-histidine

Article	Year
Trp-His, a vasorelaxant di-peptide, can inhibit extracellular Ca2+ entry to rat vascular smooth muscle cells through blockade of dihydropyridine-like L-type Ca2+ channels. Peptides, 2010, Volume: 31, Issue:11 Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Angiotensin II; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Proliferation; Dipeptides; Male; Muscle, Smooth, Vascular; Nifedipine; Nimodipine; Rats; Rats, Wistar; Verapamil	2010

Article

Year

Trp-His, a vasorelaxant di-peptide, can inhibit extracellular Ca2+ entry to rat vascular smooth muscle cells through blockade of dihydropyridine-like L-type Ca2+ channels.

Peptides, 2010, Volume: 31, Issue:11

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Angiotensin II; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Proliferation; Dipeptides; Male; Muscle, Smooth, Vascular; Nifedipine; Nimodipine; Rats; Rats, Wistar; Verapamil

2010